DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,129 filers reported holding DANAHER CORPORATION in Q1 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $11,757 | -0.5% | 50,820 | +6.7% | 0.95% | -9.8% |
| Q3 2023 | $11,821 | +44.6% | 47,648 | +39.9% | 1.05% | +52.3% |
| Q2 2023 | $8,175 | +234.8% | 34,061 | +251.6% | 0.69% | +218.0% |
| Q1 2023 | $2,442 | -48.6% | 9,688 | -45.8% | 0.22% | -51.8% |
| Q4 2022 | $4,747 | -99.9% | 17,886 | -2.8% | 0.45% | -5.5% |
| Q3 2022 | $4,755,000 | +1.0% | 18,409 | -0.9% | 0.48% | +7.0% |
| Q2 2022 | $4,708,000 | -13.8% | 18,569 | -0.2% | 0.44% | -0.2% |
| Q1 2022 | $5,459,000 | -11.8% | 18,610 | -1.1% | 0.45% | -4.3% |
| Q4 2021 | $6,191,000 | +7.4% | 18,817 | -0.6% | 0.47% | -2.9% |
| Q3 2021 | $5,762,000 | +13.1% | 18,925 | -0.3% | 0.48% | +10.6% |
| Q2 2021 | $5,095,000 | +14.1% | 18,985 | -4.3% | 0.43% | +4.6% |
| Q1 2021 | $4,466,000 | +1.4% | 19,844 | +0.1% | 0.42% | -4.4% |
| Q4 2020 | $4,406,000 | +3.7% | 19,834 | +0.5% | 0.43% | -7.5% |
| Q3 2020 | $4,250,000 | +20.4% | 19,739 | -1.1% | 0.47% | +10.9% |
| Q2 2020 | $3,529,000 | +26.6% | 19,959 | -0.9% | 0.42% | +9.6% |
| Q1 2020 | $2,787,000 | +167.0% | 20,134 | +195.9% | 0.39% | +235.7% |
| Q4 2019 | $1,044,000 | +7.4% | 6,804 | +1.1% | 0.12% | -1.7% |
| Q3 2019 | $972,000 | +1.0% | 6,729 | 0.0% | 0.12% | -1.7% |
| Q2 2019 | $962,000 | +13.3% | 6,729 | +4.6% | 0.12% | +5.3% |
| Q1 2019 | $849,000 | +29.8% | 6,434 | +1.4% | 0.11% | +15.3% |
| Q4 2018 | $654,000 | +5.5% | 6,344 | +11.2% | 0.10% | +18.1% |
| Q3 2018 | $620,000 | +12.9% | 5,704 | +2.6% | 0.08% | +5.1% |
| Q2 2018 | $549,000 | -0.7% | 5,560 | -1.6% | 0.08% | -6.0% |
| Q1 2018 | $553,000 | +5.3% | 5,651 | 0.0% | 0.08% | +3.7% |
| Q4 2017 | $525,000 | +1.7% | 5,651 | -6.0% | 0.08% | -6.9% |
| Q3 2017 | $516,000 | -33.6% | 6,011 | -34.7% | 0.09% | -33.6% |
| Q2 2017 | $777,000 | +51.2% | 9,211 | +53.2% | 0.13% | +37.9% |
| Q1 2017 | $514,000 | -28.3% | 6,011 | -34.7% | 0.10% | -34.5% |
| Q4 2016 | $717,000 | -2.6% | 9,211 | -1.9% | 0.14% | +4.3% |
| Q3 2016 | $736,000 | +14.5% | 9,385 | +47.5% | 0.14% | +6.1% |
| Q2 2016 | $643,000 | -4.0% | 6,363 | -9.9% | 0.13% | -0.8% |
| Q1 2016 | $670,000 | +2.1% | 7,063 | 0.0% | 0.13% | +2.3% |
| Q4 2015 | $656,000 | +140.3% | 7,063 | +120.7% | 0.13% | +108.1% |
| Q3 2015 | $273,000 | – | 3,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |